Agalsidase beta Injection

Agalsidase beta injection is used to treat Fabry disease (an inherited condition in which a type of fatty substance builds up in the body, resulting in nerve and organ damage) in adults and children 2 years of age and older. Agalsidase beta injection is in a class of medications called enzymes. It works by replacing an enzyme normally produced by the body that helps prevent the build up of the fatty substance in the body.

🔔 How should this medicine be used?

Agalsidase beta comes as a powder to be mixed with a liquid and injected intravenously (into a vein) by a healthcare provider. Agalsidase beta injection is usually infused (injected slowly) intravenously over a period of at least 90 minutes once every 2 weeks.

Agalsidase beta injection may cause serious adverse reactions, including allergic reactions during an infusion and for 24 hours afterwards. A doctor or nurse will monitor you carefully while you are receiving the medication. You may be given other medications to treat or prevent reactions to agalsidase beta injection. Tell your doctor or nurse immediately or seek emergency care if you experience any of the following symptoms during or shortly after your infusion: nausea; vomiting; skin redness; rash; hives; itching; swelling of the face, eyes, mouth, throat, tongue, lips, hands, feet, ankles, or lower legs; difficulty breathing or swallowing; shortness of breath; fever; headache; chest pain; feeling hot or cold; diarrhea; stomach pain; dizziness; sleepiness; nasal congestion; fast or slow heartbeat; numbness, burning, or tingling in the arms, legs, hands, or feet; or muscle, arm, or leg pain.